Home CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research
 

Keywords :   


CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research

2016-02-21 21:23:01| Biotech - Topix.net

's stock had its "buy" rating reissued by Zacks Investment Research in a research note issued on Sunday, MarketBeat Ratings reports. They currently have a $20.00 price target on the stock.

Tags: buy research rating investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
08.11Bolt drivers win right to holiday and minimum wage
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 21
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11BW Converting assists SunDance with flexible packaging pivot
08.11Sheboygan Paint Company Names New Regional Sales Managers
08.11ERI Brings AI Driven ITAD Services to Texas
08.11Irritants could disrupt U.S., Mexico trade relationship
More »